These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17625449)

  • 1. Treatment for hepatitis C virus in injection drug users on opioid replacement therapy: a prospective multicentre study.
    Belfiori B; Chiodera A; Ciliegi P; Tosti A; Baldelli F; Stagni G; Francisci D
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):731-2. PubMed ID: 17625449
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy.
    Schäfer A; Wittchen HU; Backmund M; Soyka M; Gölz J; Siegert J; Schäfer M; Tretter F; Kraus MR
    Addiction; 2009 Apr; 104(4):630-40. PubMed ID: 19335661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
    Watson B; Conigrave KM; Wallace C; Whitfield JB; Wurst F; Haber PS
    Drug Alcohol Rev; 2007 May; 26(3):231-9. PubMed ID: 17454012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of successful chronic hepatitis C case finding among patients receiving opioid maintenance treatment in a primary care setting.
    Senn O; Seidenberg A; Rosemann T
    Addiction; 2009 Dec; 104(12):2033-8. PubMed ID: 19922570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone and buprenorphine maintenance therapies for patients with hepatitis C virus infected after intravenous drug use.
    Verrando R; Robaeys G; Matheï C; Buntinx F
    Acta Gastroenterol Belg; 2005; 68(1):81-5. PubMed ID: 15832591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of hepatitis C virus infection on methadone maintenance treatment.
    Novick DM
    Mt Sinai J Med; 2000; 67(5-6):437-43. PubMed ID: 11064495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities.
    Litwin AH; Soloway I; Gourevitch MN
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S339-45. PubMed ID: 15768345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic hepatitis C with amantadine.
    Hubert IF; Lunel F; Cadranel JF; Oberti F; Calès P
    Am J Gastroenterol; 1999 Aug; 94(8):2316-7. PubMed ID: 10445578
    [No Abstract]   [Full Text] [Related]  

  • 9. [Short-time hepatitis C treatment and drug abuse].
    Kristensen Ø; Rysstad O; Gallefoss F
    Tidsskr Nor Laegeforen; 2009 Dec; 129(23):2498; author reply 2499. PubMed ID: 19997144
    [No Abstract]   [Full Text] [Related]  

  • 10. Barriers to antiviral treatment in hepatitis C infected intravenous drug users.
    Gazdag G; Horvath G; Szabo O; Ungvari GS
    Neuropsychopharmacol Hung; 2010 Dec; 12(4):459-62. PubMed ID: 21220790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse to opioid use after treatment of chronic hepatitis C with pegylated interferon and ribavirin.
    Matthews AM; Fireman M; Zucker B; Sobel M; Hauser P
    Am J Psychiatry; 2006 Aug; 163(8):1342-7; quiz 1479. PubMed ID: 16877644
    [No Abstract]   [Full Text] [Related]  

  • 12. Buprenorphine injection in Melbourne, Australia--an update.
    Aitken CK; Higgs PG; Hellard ME
    Drug Alcohol Rev; 2008 Mar; 27(2):197-9. PubMed ID: 18264882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of depression in former injection drug users with chronic hepatitis C.
    Scott JD; Wang CC; Coppel E; Lau A; Veitengruber J; Roy-Byrne P
    J Clin Gastroenterol; 2011; 45(5):462-7. PubMed ID: 21293293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating intravenous drug users with hepatitis C infection: an opportunity in some settings.
    Chong VH; Jamaludin AZ; Jacob AP; Jalihal A
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1121. PubMed ID: 16957520
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis C treatment candidacy and outcomes among 4318 US veterans with chronic hepatitis C virus infection: does a history of injection drug use matter?
    Seal KH; Currie SL; Shen H; Anand BS; Bini EJ; Brau N; Jeffers L; Wright TL;
    J Clin Gastroenterol; 2007 Feb; 41(2):199-205. PubMed ID: 17245220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of chronic hepatitis C in drug users: ethic, successful and useful].
    Remy AJ; Wenger H; Bouchkira H
    Presse Med; 2014 Dec; 43(12 Pt 1):1314-6. PubMed ID: 25307441
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
    Winstock AR; Lea T; Sheridan J
    Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of hepatitis C virus in platelets: evaluating its relationship to antiviral therapy outcome.
    de Almeida AJ; Campos-de-Magalhães M; Brandão-Mello CE; de Oliveira RV; do Espirito-Santo MP; Yoshida CF; Lampe E
    Hepatogastroenterology; 2009; 56(90):429-36. PubMed ID: 19579615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C treatment for injection drug users: a review of the available evidence.
    Hellard M; Sacks-Davis R; Gold J
    Clin Infect Dis; 2009 Aug; 49(4):561-73. PubMed ID: 19589081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to opioid maintenance treatment reduces long-term mortality.
    Gibson A; Degenhardt L; Mattick RP; Ali R; White J; O'Brien S
    Addiction; 2008 Mar; 103(3):462-8. PubMed ID: 18190664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.